So, CoreWeave (CRWV) had a pretty big Wednesday. The AI cloud infrastructure company announced a significant agreement with quantitative trading giant Jane Street. The deal includes a whopping $6 billion commitment from Jane Street to use CoreWeave's platform and a separate $1 billion equity investment in CoreWeave itself at $109 per share. That's the kind of news that usually gets a stock moving.
And yet, CoreWeave shares were basically snoozing, down a microscopic 0.068% to $117.13. Meanwhile, the broader Technology sector was up a healthy 0.69%. It's a classic case of "buy the rumor, sell the news," or perhaps more accurately, "the news was already baked in." Let's unpack why the stock isn't popping the champagne.
The Technical Picture: Overbought and Overextended
From a chart perspective, CoreWeave has been on a tear. It's currently trading 35.2% above its 20-day simple moving average and 34.5% above its 50-day SMA. That's strong short-term momentum. The long-term trend is also bullish, with the stock 13.3% above its 200-day SMA.
But here's the catch: all that running might have left it out of breath. The relative strength index (RSI) is sitting at 74.06. An RSI above 70 typically signals a stock is overbought, meaning buying pressure has potentially pushed it too far, too fast, and a pullback or consolidation could be next. Adding to the caution, the stock's 20-day SMA has recently crossed below its 50-day SMA, which is a bearish near-term signal.
Traders are watching key levels. $120 is seen as a resistance level that could cap upward moves, while $114 is viewed as a critical support level where buyers might step back in.
The underperformance against its own sector today is telling. While tech stocks are rallying, CoreWeave is treading water, hinting that its current price action is being driven by stock-specific factors, not broad market enthusiasm.
The Fundamental Backdrop: A Mixed Bag
The Jane Street deal is undeniably a huge vote of confidence. It underscores the growing demand for high-performance AI computing in fields like quantitative trading, where milliseconds and model accuracy are everything. It solidifies CoreWeave's position as a key player in that niche.
Looking ahead, the company is expected to report earnings around May 13. The estimates present a familiar growth-stage story: soaring revenue expectations paired with deepening losses. Revenue is estimated to nearly double to $1.96 billion, but the loss per share is expected to widen to -123 cents from -60 cents. The forward P/E ratio is not applicable (N/A), which is common for companies not yet profitable.
Analyst opinions are a spread. The consensus rating is a Buy with a price target of $125.47, but recent actions show a range of views:
- Bernstein: Underperform (but raised their target to $67 on April 14)
- Mizuho: Neutral (raised target to $105 on April 14)
- DA Davidson: Buy (raised target to $175 on April 13)
So, you've got one firm saying it's a sell even at $67, another in the middle at $105, and a bull seeing a path to $175. That's quite a spectrum.
The ETF Effect and Market Data Signal
CoreWeave isn't just a standalone stock; it's a meaningful holding in several exchange-traded funds (ETFs). This creates a mechanical relationship where big flows into or out of these funds can force buying or selling of CoreWeave shares, regardless of company-specific news.
That 11% weighting in the IPO ETF is particularly notable. If investors pour money into that fund, the manager has to go buy a lot of CoreWeave stock to keep up.
A look at market data signals reveals the core tension in the stock right now. On Value, it scores a weak 0.34, indicating it's trading at a steep premium compared to peers. But on Momentum, it scores a very bullish 93.42, meaning it's been dramatically outperforming the broader market. The verdict? This is a momentum story, not a value play. The price is being driven by bullish sentiment and growth expectations, not cheap fundamentals.
The Bottom Line
CoreWeave's Wednesday was a lesson in how markets digest news. A $7 billion total vote of confidence from a sophisticated player like Jane Street is massive. But when a stock is already priced for perfection—overbought, extended above its averages, and carrying a premium valuation—even great news can result in a shrug.
Investors are now looking past the headline to the next catalysts: Can the company live up to its soaring revenue estimates? When will the path to profitability become clearer? And will the overbought technical condition resolve with a healthy pullback or a period of sideways churn? For now, the stock seems to be taking a breather after a big run, even on a very good news day.
